182 related articles for article (PubMed ID: 29204164)
1. Comparison of dose volume parameters evaluated using three forward planning - optimization techniques in cervical cancer brachytherapy involving two applicators.
Chakrabarti B; Basu-Roy S; Kar SK; Das S; Lahiri A
J Contemp Brachytherapy; 2017 Oct; 9(5):431-445. PubMed ID: 29204164
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric evaluation of image based brachytherapy using tandem ovoid and tandem ring applicators.
Rangarajan R
Rep Pract Oncol Radiother; 2018; 23(1):57-60. PubMed ID: 29348735
[TBL] [Abstract][Full Text] [Related]
4. A comparison of dose distribution from Manchester-style and Fletcher-style intracavitary brachytherapy applicator systems in cervical cancer.
Basu B; Basu S; Chakraborti B; Ghorai S; Gupta P; Ghosh S; Ghosh K; Jayanti J
J Contemp Brachytherapy; 2012 Dec; 4(4):213-8. PubMed ID: 23378850
[TBL] [Abstract][Full Text] [Related]
5. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
6. Fletcher suit or ring: A comparison of Fletcher suit and ring applicators for retroverted uteri.
Rao V; Zade B; Singh S; Narayanan VKS; Moundekar P
J Contemp Brachytherapy; 2024 Apr; 16(2):128-131. PubMed ID: 38808206
[TBL] [Abstract][Full Text] [Related]
7. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
Jayarathna S; Hoang M; Badkul R; Hoover A
J Contemp Brachytherapy; 2023 Oct; 15(5):334-343. PubMed ID: 38026073
[TBL] [Abstract][Full Text] [Related]
9. A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer.
Gursel SB; Serarslan A; Meydan AD; Okumus N; Yasayacak T
J Contemp Brachytherapy; 2020 Apr; 12(2):111-117. PubMed ID: 32395134
[TBL] [Abstract][Full Text] [Related]
10. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
[TBL] [Abstract][Full Text] [Related]
11. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
[TBL] [Abstract][Full Text] [Related]
13. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
Balsdon A; Timotin E; Hunter R; Diamond K
J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
[TBL] [Abstract][Full Text] [Related]
14. Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments.
Gray T; Cherian S; Amarnath S; Guo B; Xia P; Wilkinson A
Med Dosim; 2024 Apr; ():. PubMed ID: 38616141
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
[TBL] [Abstract][Full Text] [Related]
16. Short-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary applicators.
Ma JK; Mourad WF; Allbright R; Packianathan S; Harrell LM; Chinchar E; Nguyen A; Vijayakumar S
J Contemp Brachytherapy; 2015 Jun; 7(3):218-23. PubMed ID: 26207110
[TBL] [Abstract][Full Text] [Related]
17. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator.
Bélanger C; Aubin S; Lavallée MC; Beaulieu L
Med Phys; 2024 Mar; 51(3):2128-2143. PubMed ID: 38043067
[TBL] [Abstract][Full Text] [Related]
19. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
20. High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.
Anderson JW; Xia J; Flynn RT; Modrick JM; Bhatia SK; Jacobson GM; Kim Y
J Contemp Brachytherapy; 2013 Jun; 5(2):101-9. PubMed ID: 23878555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
